X
CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19). Learn More

Histrelin Acetate (Vantas®)

Common name: Histrelin Acetate
Brand name: Vantas®
 

What is Histerlin Acetate?

Histrelin Acetate is a palliative treatment for men diagnosed with hormone-dependent advanced (metastatic) prostate cancer.
 

How is Histrelin Acetate administered?

Histerlin Acetate is a placed under the skin (subcutaneous) as a subdermal implant.
 

What are possible side effects of this treatment?

Everyone responds differently to hormone therapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received histrelin. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Abdominal pain
  • Dark urine
  • Difficulties breathing
  • Local infection
  • Loss of appetite
  • Nausea
  • Reduced testicle size
  • Vomiting
  • Weight gain
 

Is Histrelin Acetate covered in my province or territory?

Provincial/Territorial Drug Program Coverage: Unknown 
 

 
Last Reviewed: July 2017
Plaid for Dad








Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.
More

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More


Click here for news archive